Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study.
暂无分享,去创建一个
S. Kritchevsky | A. Newman | Jingzhong Ding | A. Arnold | M. Cushman | D. Ives | E. Strotmeyer | C. Hirsch | J. Kizer | N. Jenny | P. Chaves | A. Newman
[1] S. Kritchevsky,et al. Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[2] P. Libby,et al. Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10* , 2009, The Journal of Biological Chemistry.
[3] L. Fried,et al. Long‐Term Function in an Older Cohort—The Cardiovascular Health Study All Stars Study , 2009, Journal of the American Geriatrics Society.
[4] S. Anton,et al. Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.
[5] S. Cummings,et al. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study , 2009, Diabetologia.
[6] L. Kuller,et al. Adiponectin and risk of coronary heart disease in older men and women. , 2008, Journal of Clinical Endocrinology and Metabolism.
[7] R. Lipton,et al. Adiponectin levels and genotype: a potential regulator of life span in humans. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] L. Ferrucci,et al. Three‐Year Change in Inflammatory Markers in Elderly People and Mortality: The Invecchiare in Chianti Study , 2007, Journal of the American Geriatrics Society.
[9] U. Smith,et al. Culprit Underlying the Metabolic Syndrome and Atherosclerosis , 2007 .
[10] P. Whincup,et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. , 2007, Archives of internal medicine.
[11] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[12] G. Castellani,et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans , 2007, Mechanisms of Ageing and Development.
[13] E. Barrett-Connor,et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.
[14] George A Mensah,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. , 2004, Circulation.
[15] S. Toubro,et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[16] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[17] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[18] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[19] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[20] L H Kuller,et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.
[21] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[22] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[23] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[24] C. Mantzoros,et al. Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.
[25] Vicente Bertomeu Martínez,et al. Markers of Inflammation and Cardiovascular Disease , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[26] M. Bots,et al. rediction of Mortality Risk in the Elderly , 2006 .
[27] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.